Core Insights - Omada Health, Inc. reported revenue of $68.03 million for the quarter ended September 2025, showing no change compared to the same period last year, with an EPS of $0.02 compared to $0 in the year-ago quarter [1] - The revenue exceeded the Zacks Consensus Estimate of $61.15 million by 11.25%, and the EPS surpassed the consensus estimate of -$0.10 by 120% [1] Financial Performance - Total members reached 831,000, exceeding the two-analyst average estimate of 779,290 [4] - Revenue from hardware was $5.09 million, surpassing the average estimate of $4.44 million [4] - Revenue from services was $62.94 million, compared to the average estimate of $56.71 million [4] Market Performance - Over the past month, shares of Omada Health, Inc. returned -2.8%, while the Zacks S&P 500 composite increased by 1.3% [3] - The stock currently holds a Zacks Rank 4 (Sell), indicating potential underperformance relative to the broader market in the near term [3]